Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

November 30, 2009

Conditions
Post Traumatic Stress Disorder (PTSD)
Interventions
DRUG

SYN117 (nepicastat)

120 mg per day

DRUG

Placebo comparator

once per day placebo capsules

Trial Locations (3)

29401

Ralph H. Johnson VA Medical Center, Charleston

35404

Tuscaloosa VAMC, Tuscaloosa

77030

Michael E. Debakey VAMC, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Tuscaloosa Veterans Affairs Medical Center

FED

collaborator

Ralph H. Johnson VA Medical Center

FED

collaborator

Acorda Therapeutics

INDUSTRY

lead

Michael E. DeBakey VA Medical Center

FED